• G03416

RES
1b:x-dglc-HEX-1:5
2b:b-dgal-HEX-1:5
3b:a-dgal-HEX-1:5
LIN
1:1o(4+1)2d
2:2o(4+1)3d

• Naiki M et al. An immunochemical study of the human blood group P1, P, and PK glycosphingolipid antigens. Biochemistry. 1975 Nov 4;14:(22):4837-41. doi: 10.1021/bi00693a010. PMID: 1182122.

• Oosterwijk E et al. Monoclonal antibodies against Gal alpha 1-4Gal beta 1-4Glc (Pk, CD77) produced with a synthetic glycoconjugate as immunogen: reactivity with carbohydrates, with fresh frozen human tissues and hematopoietic tumors. Int J Cancer. 1991 Jul 30;48:(6):848-54. doi: 10.1002/ijc.2910480610. PMID: 1860732.

• Kojima Y et al. Molecular cloning of globotriaosylceramide/CD77 synthase, a glycosyltransferase that initiates the synthesis of globo series glycosphingolipids. J Biol Chem. 2000 May 19;275:(20):15152-6. doi: 10.1074/jbc.M909620199. PMID: 10748143.

• Cooling LL et al. Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid. Infect Immun. 1998 Sep;66:(9):4355-66. PMID: 9712788.

• Okuda T et al. Targeted disruption of Gb3/CD77 synthase gene resulted in the complete deletion of globo-series glycosphingolipids and loss of sensitivity to verotoxins. J Biol Chem. 2006 Apr 14;281:(15):10230-5. doi: 10.1074/jbc.M600057200. PMID: 16476743.